Loading viewer...
investor_presentation
Format: PDF investor_presentation
CELLINK presented its bioconvergence strategy addressing modern healthcare challenges including high drug development costs, high clinical trial failure rates, and organ transplant shortages. The presentation highlights how the company's technology addresses limitations in traditional drug development and organ availability.
investor_presentation
17 Pages
Joby Aviation
Kintara Therapeutics Investor Presentation — June 2022
investor_presentationinvestor_presentation
22 Pages
Kintara Therapeutics, Inc.
